key: cord-0886992-ionzngz6
authors: Siow, Isabel; Lee, Keng Siang; Zhang, John J.Y.; Saffari, Seyed Ehsan; Ng, Adeline; Young, Barnaby
title: Reply to Letter to Editor
date: 2021-05-24
journal: J Stroke Cerebrovasc Dis
DOI: 10.1016/j.jstrokecerebrovasdis.2021.105881
sha: 81beeb58d2662422eb46854388f64036cef29c1f
doc_id: 886992
cord_uid: ionzngz6

nan

We sincerely thank Dr Au for the interest in our article, "Stroke as a Neurological Complication of COVID-19: A Systematic Review and Meta Analysis of Incidence, Outcomes and Predictors" and her concern regarding possible overlap between some of the studies included in our analysis. This has been a significant issue for researchers conducting systematic reviews during the COVID-19 pandemic as the urgent need for data can result in datasets being included in multiple manuscripts but their providence not clearly reported.

While conducting the systematic review we excluded studies where there was clear evidence of overlap. However, we agree that it is important to readdress this for the studies in question, namely: (i) Nalleballe et al. 1 To exclude this possibility and to address Dr Au's concern, we have performed further sensitivity analyses.

Subsequent sensitivity analyses yielded minimal changes between the pooled results originally published in our study and after including the above-mentioned studies. Patient demographics including age (Mean age: 65.5 years in original article vs 65.7 years in revised analysis), percentage of males (70.5% vs 73.2%) and admission NIHSS score (Mean: 17.9 vs 15.2) were similar in both analyses. The comorbidity profiles were also similar. The proportion of patients with ischaemic stroke (compared to haemorrhagic stroke) was similar between original and revised analyses (82.8% vs 81.3%). Incidence of stroke as a complication for COVID-19 was slightly lower in our original analysis than in our revised analyses (1.74% vs 2.69%). The mortality rate of COVID-19 patient who developed stroke was similar between original and revised analyses (31.8% vs 31.0%) (Figs. 1À3, Tables 1À3).

In conclusion, despite the possible overlap in patients between a few of the studies, the pooled results in our 

Spectrum of neuropsychiatric manifestations in COVID-19

COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome

SARS-CoV-2 and stroke in a New York healthcare system

Neurological and neuropsychiatric complications of COVID-19 in 153 patients: A UK-wide surveillance study

Characteristics of ischaemic stroke associated with COVID-19

Intracerebral haemorrhage (ICH) and COVID-19: clinical characteristics from a case series

COVID-19 is an independent risk factor for acute ischemic stroke

Incidental COVID-19 related lung apical findings on stroke CTA during the COVID-19 pandemic